PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Dec-2025 Eikon Therapeutics Announces the Election of David W. Meline to its Board of Directors Businesswire
02-Dec-2025 Strand Therapeutics Appoints Jeb Keiper to Board of Directors Businesswire
02-Dec-2025 Latus Bio Announces IND Clearance of LTS-101 for CLN2 Disease and Receipt of Fast Track, Orphan Drug, and Rare Pediatric Disease Designations Businesswire
02-Dec-2025 IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform Businesswire
02-Dec-2025 QurAlis to Present Data From its Phase 1 Clinical Trial of QRL-101, a Potential Best-in-Class Selective Kv7.2/7.3 Ion Channel Opener, at American Epilepsy Society 2025 Annual Meeting Businesswire
02-Dec-2025 enGene’s Detalimogene Selected for FDA Manufacturing Pilot Program to Support Manufacturing Readiness Businesswire
02-Dec-2025 President Trump's Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution ACCESS Newswire
02-Dec-2025 ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions Businesswire
02-Dec-2025 Valo Health Appoints Rita Kale as Chief Financial Officer Businesswire
02-Dec-2025 PumasAI’s AskPumas Surpasses 15,000 Questions Answered as Global Use of AI Tools in Drug Development Accelerates PumasAI
02-Dec-2025 eXmoor Pharma and UCL forge a strategic collaboration to speed the advancement of cell and gene therapies eXmoor Pharma, UCL
02-Dec-2025 Evestia Clinical Announces New Strategic Advisory Board to Advance Specialist CRO Capabilities Worldwide Evestia Clinical
02-Dec-2025 Egle Therapeutics Initiates Phase 1 Healthy Volunteer Study of EGL-003, a Next Generation Treg IL-2 Agonist for Atopic Dermatitis Businesswire
02-Dec-2025 Imvax Announces Positive Top-line Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM Businesswire
02-Dec-2025 Tema’s Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance Businesswire
02-Dec-2025 Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms ACCESS Newswire
02-Dec-2025 Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer Zelluna ASA
02-Dec-2025 Xlife Sciences AG Delivers Breakthrough in Early Alzheimer’s Detection, Unlocking Major Market Opportunity Xlife Sciences AG
02-Dec-2025 New insights into NHS prescribing for care home patients aged 65 and over released NHS
02-Dec-2025 Lundbeck to present comprehensive new bexicaserin dataset in patients with rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting Lundbeck